Concepedia

LeeAnn Machiesky

LM

Statistics

Publications

7

Citations

328

H-Index

7

Active since

2013

Affiliations

AstraZeneca (United States)(Current)

LeeAnn Machiesky is an author at AstraZeneca (United States) specializing in immunology, monoclonal antibodies, and antibody engineering.

Publications per year

2013–2023

7

Publications

7

ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome

Alexander T. Baker, Ryan J. Boyd, Daipayan Sarkar et al. · Science Advances · 2021 · 172 citations · Full text

Medicine, Hematology, Molecular Biology +8

Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding

Xiaojun Lu, LeeAnn Machiesky, Niluka De Mel et al. · Scientific Reports · 2020 · 47 citations · Full text

Pharmacy, Biochemistry, Immunology +17

Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection

Tyler Brady, Corinne Cayatte, Scott D. Speer et al. · Frontiers in Immunology · 2023 · 32 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer

Darren J. Schofield, Jennifer Percival‐Alwyn, Mateusz Rytelewski et al. · mAbs · 2021 · 30 citations · Full text

Life Sciences, Immunology, Oncology +17

Monovalent IgG4 molecules

Ian Wilkinson, Susan A. Fowler, LeeAnn Machiesky et al. · mAbs · 2013 · 19 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

1–5 of 7